Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03517137
Title Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study (COBRA)
Acronym COBRA
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Age Groups: senior | adult
Covered Countries NLD | ESP | BEL

Facility Status City State Zip Country Details
ZNA Stuivenberg Antwerp 2060 Belgium Details
Universitair Ziekenhuis Antwerpen Edegem 2650 Belgium Details
U.Z. Leuven - Campus Gasthuisberg Leuven 3000 Belgium Details
University Hospitals Copenhagen - Rigshospitalet Copenhagen 2100 Denmark Details
Amsterdam UMC - Locatie AMC Amsterdam 1105 Netherlands Details
Deventer Ziekenhuis Deventer 7400 Netherlands Details
University Medical Center Groningen Groningen 9713 Netherlands Details
Medisch Centrum Leeuwarden-Zuid Leeuwarden 8934 Netherlands Details
Haaglanden Medisch Centrum (HMC) - Haaglanden MC - locatie Antoniushove Leidschendam 2262 Netherlands Details
Radboudumc - Radboud University Medical Center Nijmegen Nijmegen 6525 Netherlands Details
Erasmus MC Rotterdam 3015 Netherlands Details
Maria Sklodowska Curie National Institute of Oncology - National Research Institute Warsaw 02781 Poland Details
Instituto Portugues De Oncologia - Francisco Gentil - Centro De Lisboa Lisboa 1099 Portugal Details
National Cancer Institute Bratislava 833 Slovakia Details
Hospital Duran i Reynals (Institut Catala D'Oncologia) L'Hospitalet De Llobregat 08908 Spain Details
Complejo Hospitalario de Navarra Pamplona 31008 Spain Details
*Shaded cells indicate that there was no data available from for the field